Delivery Order SPE2DB20D2104-SPE2DB25FNAJG
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,310.25 for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,670.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL Solution in unit dose vials. The order, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a pharmaceutical supply delivery supporting federal medical procurement needs. This delivery order is classified as a child contract under AmerisourceBergen's broader federal contracting relationship and involves no set-aside...
- The Defense Logistics Agency awarded a $1,973.31 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials, with a ceiling value of $8,823.72. This non-competitive delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed price pricing and represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,261.31 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $12,791 to Amerisourcebergen Drug Corporation for 4562158368 YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 13-14, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, with a ceiling value of $3,330.74 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- This is a $1,697.81 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract provides for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to support federal government medical requirements. The contract has a period of performance through May 8, 2024 and was not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $23,940.27 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, with an ultimate completion date of August 28, 2025. The delivery order, issued without set-aside designation through competitive procedures, covers TRELEGY ELLIPTA 200-62.5-25 (a combination inhalation medication for chronic obstructive pulmonary disease) in a 60-unit...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAJGDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,309.90 on September 12, 2025, for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contractor serves customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its established capability to meet federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/12/25 |